Blog Posts

Antonio Passaro: Must read for all those interested in solid tumor cell therapy

Antonio Passaro/X

Feb 13, 2025, 09:52

Antonio Passaro: Must read for all those interested in solid tumor cell therapy

Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, shared a post by Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, on LinkedIn, adding:

“A must-read for anyone interested in solid tumor cell therapy! This article offers essential practical insights for optimizing TIL therapy application.
Kudos to all coauthors, and especially to my friend Marco Donia for this outstanding work!”

Quoting Marco Donia’s post:

“Art of TIL (tumor-infiltrating lymphocyte) therapy: Society for Immunotherapy of Cancer (SITC) perspective on demystifying a complex treatment

(Free Access on Journal for ImmunoTherapy of Cancer, Jan 20th 2025)

Must read for all those interested in solid tumor cell therapy

Check our practical considerations for best practices to apply TIL therapy

Thanks to all coauthors, in particular Simon Turcotte and Stephanie Goff for leading this effort!”

Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment

Authors: Simon Turcotte, et al.

Antonio Passaro: Must read for all those interested in solid tumor cell therapy

Antonio Passaro Benjamin Creelan Brian Gastman cancer George Coukos Inge Marie Svane James C. Yang John B.A.G. Haanen John Mullinax Maartje W Rohaan Marco Donia Michael T Lotze Michal Besser OncoDaily Oncology Robert Brown Simon Turcotte Stephanie L. Goff Vernon K Sondak

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders